Ireland· IE-PA-PA1024/003/001
Hexvix 85 mg, powder and solvent for intravesical solution
A other diagnostic agents product containing hexaminolevulinate hydrochloride, registered in Ireland by Photocure ASA. The same ATC class is registered in 11 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Hexaminolevulinate hydrochloride is registered in 11 of 19 countries.
Countries holding a registration under ATC V04CX (other diagnostic agents), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 7 of them publish a price we can compare per daily dose
Hexaminolevulinate hydrochloride · ATC V04CX
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
HPRA (Ireland)- Active substance
- Hexaminolevulinate hydrochloride
- Manufacturer
- Photocure ASA
- Country
- Ireland (IE)
- ATC code
- V04CX
- ATC class
- Other diagnostic agents
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA1024/003/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Hexaminolevulinate hydrochloride in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandHexvix2care4 ApS
- SpainHEXVIX 85 mg POLVO Y DISOLVENTE PARA SOLUCION INTRAVESICALPhotocure Asa
- FranceHEXVIX 85 mg, poudre et solvant pour solution intravésicalePHOTOCURE ASA
- United KingdomHexvix 85mg powder and solvent for intravesical solution vialsPhotocure ASA
- IcelandHexvixPhotocure ASA
- NorwayHexvixPhotocure ASA
- BelgiumHexvix 85 mgPhotoCure
- SwedenHexvix 85 mg Pulver och vätska till intravesikal lösningPhotocure ASA
Authorised across Europe · EMA
The same active substance is authorised in 22 EEA countries. Names it is sold under:
- Austria · Hexvix
- Belgium · Hexvix
- Czechia · Hexvix
- Germany · Hexvix
- Denmark · Hexvix
- Estonia · Hexvix
- Spain · Hexvix
- Finland · Hexvix
- France · Hexvix
- United Kingdom (Northern Ireland) · Hexvix
- Greece · Hexvix
- Hungary · Hexvix
- Iceland · Hexvix
- Italy · Hexvix
- Lithuania · Hexvix
- Latvia · Hexvix
- Netherlands · Hexvix
- Norway · Hexvix
- Poland · Hexvix
- Portugal · Hexvix
- Sweden · Hexvix
- Slovenia · Hexvix
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/7b4196aa-8c95-46d7-a9ae-5bfdb3bc86b6 GET /v1/drugs/7b4196aa-8c95-46d7-a9ae-5bfdb3bc86b6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Powder and solvent for intravesical solution",
"routes": [
"Intravesical use"
],
"source": "hpra",
"atc_all": [
"V04CX"
],
"strength": null,
"pa_number": "PA1024/003/001",
"substances": [
"Hexaminolevulinate hydrochloride"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Not marketed",
"authorised_at": "23/02/2007",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about hexaminolevulinate hydrochloride.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.